Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion

NeuroImage

Volumn 62, Issue 1, 2012, Pages 229-238

  Westman, Eric ^a   Muehlboeck, J Sebastian ^a   Simmons, Andrew ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b King s College London   (United Kingdom)

Author keywords

AD; CSF; MCI conversion; MRI; OPLS

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN SIZE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL LEAST SQUARES REGRESSION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 84861645859     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.04.056     Document Type: Article

References (59)

1. Apostolova L.G., Hwang K.S., Andrawis J.P., Green A.E., Babakchanian S., Morra J.H., Cummings J.L., Toga A.W., Trojanowski J.Q., Shaw L.M., Jack C.R., Petersen R.C., Aisen P.S., Jagust W.J., Koeppe R.A., Mathis C.A., Weiner M.W., Thompson P.M. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol. Aging 2010, 31:1284-1303.
2. Bylesjo M., Eriksson D., Kusano M., Moritz T., Trygg J. Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. Plant J. 2007, 52:1181-1191.
3. Cui Y., Liu B., Luo S., Zhen X., Fan M., Liu T., Zhu W., Park M., Jiang T., Jin J.S., the Alzheimer's Disease Neuroimaging, I Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One 2011, 6:e21896.
4. Cuingnet R., Gerardin E., Tessieras J., Auzias G., Lehericy S., Habert M.O., Chupin M., Benali H., Colliot O. Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage 2011, 56:766-781.
5. Dale A.M., Sereno M.I. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J. Cogn. Neurosci. 1993, 5:162-176.
6. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9:179-194.
7. Davatzikos, C., Bhatt, P., Shaw, L.M., Batmanghelich, K.N., Trojanowski, J.Q., 2011. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol. Aging 32 (12), 2322.e19-27. Epub 2010 Jul 1.
8. Desikan R.S., Ségonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980.
9. Dubois B., Feldman H.H., Jacova C., DeKosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6:734-746.
10. Eriksson L., Johansson E., Kettaneh-Wold N., Trygg J., Wiksröm C., Wold S. Multi- and Megavariate Data Analysis (Part I - Basics and Principals and Applications) 2006, Umetrics AB, Umeå. 2nd ed.
11. Ewers, M., Walsh, C., Trojanowski, J.Q., Shaw, L.M., Petersen, R.C., Jack Jr, C.R., Feldman, H.H., Bokde, A.L.W., Alexander, G.E., Scheltens, P., Vellas, B., Dubois, B., Weiner, M., Hampel, H., in press. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol. Aging 2010 Dec 13. [Epub ahead of print].
12. Fan Y., Resnick S.M., Wu X., Davatzikos C. Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage 2008, 41:277-285.
13. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11050-11055.
14. Fischl B., Sereno M.I., Tootell R.B., Dale A.M. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 1999, 8:272-284.
15. Fischl B., Liu A., Dale A.M. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans. Med. Imaging 2001, 20:70-80.
16. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
17. Fischl B., Salat D.H., van der Kouwe A.J., Makris N., Segonne F., Quinn B.T., Dale A.M. Sequence-independent segmentation of magnetic resonance images. Neuroimage 2004, 23(Suppl. 1):S69-84.
18. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Segonne F., Salat D.H., Busa E., Seidman L.J., Goldstein J., Kennedy D., Caviness V., Makris N., Rosen B., Dale A.M. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14:11-22.
19. Fjell A.M., Westlye L.T., Amlien I., Espeseth T., Reinvang I., Raz N., Agartz I., Salat D.H., Greve D.N., Fischl B., Dale A.M., Walhovd K.B. High consistency of regional cortical thinning in aging across multiple samples. Cereb. Cortex 2009, 19:2001-2012.
20. Fjell A.M., Walhovd K.B., Fennema-Notestine C., McEvoy L.K., Hagler D.J., Holland D., Brewer J.B., Dale A.M. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J. Neurosci. 2010, 30:2088-2101.
21. Hinrichs C., Singh V., Mukherjee L., Xu G., Chung M.K., Johnson S.C. Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset. Neuroimage 2009, 48:138-149.
22. Hinrichs C., Singh V., Xu G., Johnson S. MKL for robust multi-modality AD classification. Med. Image Comput. Comput. Assist. Interv. 2009, 12:786-794.
23. Johan Trygg S.W. Orthogonal projections to latent structures (O-PLS). J. Chemometr. 2002, 16:119-128.
24. Kohannim O., Hua X., Hibar D.P., Lee S., Chou Y.-Y., Toga A.W., Jack C.R., Weiner M.W., Thompson P.M. Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol. Aging 2010, 31:1429-1442.
25. Landau S.M., Harvey D., Madison C.M., Reiman E.M., Foster N.L., Aisen P.S., Petersen R.C., Shaw L.M., Trojanowski J.Q., Jack C.R., Weiner M.W., Jagust W.J. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010, 75:230-238.
26. Levine B., Kovacevic N., Nica E.I., Cheung G., Gao F., Schwartz M.L., Black S.E. The Toronto traumatic brain injury study: injury severity and quantified MRI. Neurology 2008, 70:771-778.
27. Liu Y., Paajanen T., Westman E., Wahlund L.O., Simmons A., Tunnard C., Sobow T., Proitsi P., Powell J., Mecocci P., Tsolaki M., Vellas B., Muehlboeck S., Evans A., Spenger C., Lovestone S., Soininen H. Effect of APOE epsilon4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J. Alzheimers Dis. 2010, 21:947-966.
28. Liu Y., Paajanen T., Westman E., Zhang Y., Wahlund L.O., Simmons A., Tunnard C., Sobow T., Proitsi P., Powell J., Mecocci P., Tsolaki M., Vellas B., Muehlboeck S., Evans A., Spenger C., Lovestone S., Soininen H. APOE epsilon2 allele is associated with larger regional cortical thicknesses and volumes. Dement. Geriatr. Cogn. Disord. 2010, 30:229-237.
29. Liu Y., Paajanen T., Zhang Y., Westman E., Wahlund L.-O., Simmons A., Tunnard C., Sobow T., Mecocci P., Tsolaki M., Vellas B., Muehlboeck S., Evans A., Spenger C., Lovestone S., Soininen H. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol. Aging 2010, 31:1375-1385.
30. Liu Y., Paajanen T., Zhang Y., Westman E., Wahlund L.O., Simmons A., Tunnard C., Sobow T., Mecocci P., Tsolaki M., Vellas B., Muehlboeck S., Evans A., Spenger C., Lovestone S., Soininen H. Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups - the AddNeuroMed study. Neurobiol. Aging 2011, 32:1198-1206.
31. McEvoy L.K., Holland D., Hagler D.J., Fennema-Notestine C., Brewer J.B., Dale A.M. Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology 2011, 259:834-843.
32. McIntosh A.R., Lobaugh N.J. Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage 2004, 23:S250-S263.
33. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
34. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
35. Nettiksimmons J., Harvey D., Brewer J., Carmichael O., DeCarli C., Jack C.R., Petersen R., Shaw L.M., Trojanowski J.Q., Weiner M.W., Beckett L. Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiol. Aging 2010, 31:1419-1428.
36. Qizilbash S., Chui, Tariot, Brodaty, Kaye, Erkinjuntti Evidenced-based Dementia Practice 2002, Blackwell Publishing, Oxford, 20-23pp.
37. Rantalainen M., Cloarec O., Beckonert O., Wilson I.D., Jackson D., Tonge R., Rowlinson R., Rayner S., Nickson J., Wilkinson R.W., Mills J.D., Trygg J., Nicholson J.K., Holmes E. Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J. Proteome Res. 2006, 5:2642-2655.
38. Scheltens P., Rockwood K. How golden is the gold standard of neuropathology in dementia?. Alzheimers Dement. 2011, 7:486-489.
39. Segonne F., Dale A.M., Busa E., Glessner M., Salat D., Hahn H.K., Fischl B. A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004, 22:1060-1075.
40. Segonne F., Pacheco J., Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans. Med. Imaging 2007, 26:518-529.
41. Simmons A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., Kloszewska I., Wahlund L.-O., Soininen H., Lovestone S., Evans A., Spenger C. MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann. N. Y. Acad. Sci. 2009, 1180:47-55.
42. Simmons, A., Westman, E., Muehlboeck, S., Mecocci, P., Vellas, B., Tsolaki, M., Kloszewska, I., Wahlund, L.-O., Soininen, H., Lovestone, S., Evans, A., Spenger, C., for the AddNeuroMed consortium, 2011. The AddNeuroMed framework for multicentre MRI assessment of longitudinal changes in Alzheimer's disease: experience from the first 24 months. Int. J. Geriatr. Psychiatry 26 (1), 75-82.
43. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
44. Thambisetty M., Simmons A., Velayudhan L., Hye A., Campbell J., Zhang Y., Wahlund L.O., Westman E., Kinsey A., Guntert A., Proitsi P., Powell J., Causevic M., Killick R., Lunnon K., Lynham S., Broadstock M., Choudhry F., Howlett D.R., Williams R.J., Sharp S.I., Mitchelmore C., Tunnard C., Leung R., Foy C., O'Brien D., Breen G., Furney S.J., Ward M., Kloszewska I., Mecocci P., Soininen H., Tsolaki M., Vellas B., Hodges A., Murphy D.G., Parkins S., Richardson J.C., Resnick S.M., Ferrucci L., Wong D.F., Zhou Y., Muehlboeck S., Evans A., Francis P.T., Spenger C., Lovestone S. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch. Gen. Psychiatry 2010, 67:739-748.
45. Trygg J., Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemometr. 2002, 16:119-128.
46. Trygg J., Wold S. O2-PLS, a two-block (X-Y) latent variable regression (LVR) method with an integral OSC filter. J. Chemometr. 2003, 17:53-64.
47. Umetrics Users guide to SIMCA-P+ http://www.umetrics.com/Content/Document%20Library/Files/UserGuides-Tutorials/SIMCA-P_12_UG.pdf.
48. Walhovd K.B., Fjell A.M., Brewer J., McEvoy L.K., Fennema-Notestine C., Hagler D.J., Jennings R.G., Karow D., Dale A.M. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am. J. Neuroradiol. 2010, 31:347-354.
49. Walhovd K.B., Westlye L.T., Amlien I., Espeseth T., Reinvang I., Raz N., Agartz I., Salat D.H., Greve D.N., Fischl B., Dale A.M., Fjell A.M. Consistent neuroanatomical age-related volume differences across multiple samples. Neurobiol. Aging 2011, 32:916-932.
50. Westman E., Spenger C., Oberg J., Reyer H., Pahnke J., Wahlund L.O. In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment. BMC Neurosci. 2009, 10:33.
51. Westman E., Wahlund L.O., Foy C., Poppe M., Cooper A., Murphy D., Spenger C., Lovestone S., Simmons A. Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. J. Alzheimers Dis. 2010, 22:171-181.
52. Westman E., Simmons A., Muehlboeck J.S., Mecocci P., Vellas B., Tsolaki M., Kloszewska I., Soininen H., Weiner M.W., Lovestone S., Spenger C., Wahlund L.O. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage 2011, 58:818-828.
53. Westman, E., Cavallin, L., Zhang, Y., Muehlboeck, J.S., Mecocci, P., Vellas, B., Tsolaki, M., Kloszewska, I., Soininen, H., Spenger, C., Lovestone, S., Simmons, A., Wahlund, L.O., 2011b. Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer's Disease. PLoS ONE. 6 (7), e22506.
54. Westman E., Simmons A., Zhang Y., Muehlboeck J.S., Tunnard C., Liu Y., Collins L., Evans A., Mecocci P., Vellas B., Tsolaki M., Kloszewska I., Soininen H., Lovestone S., Spenger C., Wahlund L.O. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage 2011, 54:1178-1187.
55. Wiklund S., Johansson E., Sjostrom L., Mellerowicz E.J., Edlund U., Shockcor J.P., Gottfries J., Moritz T., Trygg J. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 2008, 80:115-122.
56. Wold S., Ruhe A., Wold H., Dunn W.J. The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses. SIAM J. Sci. Stat. Comput. 1984, 5:735-743.
57. Wold S., Sjostrom M., Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometr. Intell. Lab. Syst. 2001, 58:109-130.
58. Wold S., Trygg J., Berglund A., Antti H. Some recent developments in PLS modeling. Chemometr. Intell. Lab. Syst. 2001, 58:131-150.
59. Zhang D., Wang Y., Zhou L., Yuan H., Shen D. Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 2011, 55:856-867.